Over-expression of Follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice

Metabolism: Clinical and Experimental

Volumn 64, Issue 2, 2015, Pages 283-295

  Brandt, Claus ^a   Hansen, Rasmus Hvass ^b   Hansen, Jakob Bondo ^c   Olsen, Caroline Holkmann ^b   Galle, Pia ^a   Mandrup Poulsen, Thomas ^c,d   Gehl, Julie ^b   Pedersen, Bente Klarlund ^a   Hojman, Pernille ^a  

^a University of Copenhagen   (Denmark)

^b Mental Health Center Glostrup   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Fasting response; Fstl3; Glucagon sensitivity; Insulin sensitivity; Whole body metabolism

Indexed keywords

ACTIVIN A; FAT; FOLLISTATIN; FOLLISTATIN LIKE 3; GLUCAGON; GLUCOSE; INSULIN; MYOSTATIN; UNCLASSIFIED DRUG; ACTIVIN; FSTL3 PROTEIN, MOUSE; MSTN PROTEIN, MOUSE; PROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIET INDUCED OBESITY; DIET RESTRICTION; ELECTROPORATION; FAT INTAKE; FEMALE; FOOD INTAKE; GASTROCNEMIUS MUSCLE; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID STORAGE; LIVER; METABOLIC PARAMETERS; MORPHOLOGY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ISLET; QUADRICEPS FEMORIS MUSCLE; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; TIBIALIS ANTERIOR MUSCLE; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CYTOLOGY; GENETICS; GLUCOSE INTOLERANCE; GROWTH, DEVELOPMENT AND AGING; LIPID DIET; METABOLISM; MUSCLE DEVELOPMENT; OBESITY; PATHOLOGY; RANDOMIZATION; SKELETAL MUSCLE; UPREGULATION;

ACTIVINS; ADIPOSITY; ANIMALS; DIET, HIGH-FAT; FEMALE; GLUCAGON; GLUCOSE INTOLERANCE; INSULIN; INSULIN RESISTANCE; ISLETS OF LANGERHANS; LIVER; MICE, INBRED C57BL; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOSTATIN; PROTEINS; RANDOM ALLOCATION; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SUBCUTANEOUS FAT; UP-REGULATION;

EID: 84920589580     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.10.007     Document Type: Article

References (46)

1. N.K. LeBrasseur, K. Walsh, and Z. Arany Metabolic benefits of resistance training and fast glycolytic skeletal muscle Am J Physiol Endocrinol Metab 300 1 2011 E3 E10
2. B. Egan, and J.R. Zierath Exercise metabolism and the molecular regulation of skeletal muscle adaptation Cell Metab 17 2 2013 162 184
3. B.K. Pedersen Muscle as a secretory organ Compr Physiol 3 3 2013 1337 1362
4. G.C. Laurentino, C. Ugrinowitsch, H. Roschel, M.S. Aoki, A.G. Soares, and M. Neves Jr. Strength training with blood flow restriction diminishes myostatin gene expression Med Sci Sports Exerc 44 3 2012 406 412
5. J. Henningsen, K.T. Rigbolt, B. Blagoev, B.K. Pedersen, and I. Kratchmarova Dynamics of the skeletal muscle secretome during myoblast differentiation Mol Cell Proteomics 9 11 2010 2482 2496
6. D.S. Willoughby Effects of heavy resistance training on myostatin mRNA and protein expression Med Sci Sports Exerc 36 4 2004 574 582
7. D.S. Willoughby, and L. Taylor Effects of concentric and eccentric muscle actions on myostatin and follistatin-like related gene J Sports Sci Med 3 2004 226 233
8. K. Tsuchida, K.Y. Arai, Y. Kuramoto, N. Yamakawa, Y. Hasegawa, and H. Sugino Identification and characterization of a novel follistatin-like protein as a binding protein for the TGF-beta family J Biol Chem 275 52 2000 40788 40796
9. Y. Sidis, A. Mukherjee, H. Keutmann, A. Delbaere, M. Sadatsuki, and A. Schneyer Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins Endocrinology 147 7 2006 3586 3597
10. J.J. Hill, M.V. Davies, A.A. Pearson, J.H. Wang, R.M. Hewick, and N.M. Wolfman The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum J Biol Chem 277 43 2002 40735 40741
11. J.N. Cash, E.B. Angerman, C. Kattamuri, K. Nolan, H. Zhao, and Y. Sidis Structure of myostatin.follistatin-like 3: N-terminal domains of follistatin-type molecules exhibit alternate modes of binding J Biol Chem 287 2 2012 1043 1053
12. I. Akpan, M.D. Goncalves, R. Dhir, X. Yin, E.E. Pistilli, and S. Bogdanovich The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity Int J Obes (Lond) 33 11 2009 1265 1273
13. T. Guo, W. Jou, T. Chanturiya, J. Portas, O. Gavrilova, and A.C. McPherron Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity PLoS One 4 3 2009 e4937
14. A.C. McPherron, and S.J. Lee Suppression of body fat accumulation in myostatin-deficient mice J Clin Invest 109 5 2002 595 601
15. C. Brandt, A.R. Nielsen, C.P. Fischer, J. Hansen, B.K. Pedersen, and P. Plomgaard Plasma and muscle myostatin in relation to type 2 diabetes PLoS One 7 5 2012 e37236
16. D.S. Hittel, J.R. Berggren, J. Shearer, K. Boyle, and J.A. Houmard Increased secretion and expression of myostatin in skeletal muscle from extremely obese women Diabetes 58 1 2009 30 38
17. D.S. Hittel, M. Axelson, N. Sarna, J. Shearer, K.M. Huffman, and W.E. Kraus Myostatin decreases with aerobic exercise and associates with insulin resistance Med Sci Sports Exerc 42 11 2010 2023 2029
18. H. Wu, M. Wu, Y. Chen, C.A. Allan, D.J. Phillips, and M.P. Hedger Correlation between blood activin levels and clinical parameters of type 2 diabetes Exp Diabetes Res 2012 2012 410579 10.1155/2012/410579
19. L. Li, J.J. Shen, J.C. Bournat, L. Huang, A. Chattopadhyay, and Z. Li Activin signaling: effects on body composition and mitochondrial energy metabolism Endocrinology 150 8 2009 3521 3529
20. A. Mukherjee, Y. Sidis, A. Mahan, M.J. Raher, Y. Xia, and E.D. Rosen FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults Proc Natl Acad Sci U S A 104 4 2007 1348 1353
21. L. Pedersen, C.H. Olsen, B.K. Pedersen, and P. Hojman Muscle-derived expression of the chemokine CXCL1 attenuates diet-induced obesity and improves fatty acid oxidation in the muscle Am J Physiol Endocrinol Metab 302 7 2012 E831 E840
22. P. Hojman, C. Brolin, H. Gissel, C. Brandt, B. Zerahn, and B.K. Pedersen Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in muscles PLoS One 4 6 2009 e5894
23. J.V. Passonneau, P.D. Gatfield, D.W. Schulz, and O.H. Lowry An enzymic method for measurement of glycogen Anal Biochem 19 2 1967 315 326
24. H. Klein, L. Garneau, N.T. Trinh, A. Prive, F. Dionne, and E. Goupil Inhibition of the KCa3.1 channels by AMP-activated protein kinase in human airway epithelial cells Am J Physiol Cell Physiol 296 2 2009 C285 C295
25. J. Hansen, C. Brandt, A.R. Nielsen, P. Hojman, M. Whitham, and M.A. Febbraio Exercise induces a marked increase in plasma follistatin: evidence that follistatin is a contraction-induced hepatokine Endocrinology 152 1 2011 164 171
26. J.B. Hansen, M.F. Tonnesen, A.N. Madsen, P.H. Hagedorn, J. Friberg, and L.G. Grunnet Divalent metal transporter 1 regulates iron-mediated ROS and pancreatic beta cell fate in response to cytokines Cell Metab 16 4 2012 449 461
27. S.J. Choi, Z. Yablonka-Reuveni, K.J. Kaiyala, K. Ogimoto, M.W. Schwartz, and B.E. Wisse Increased energy expenditure and leptin sensitivity account for low fat mass in myostatin-deficient mice Am J Physiol Endocrinol Metab 300 6 2011 E1031 E1037
28. C. Zhang, C. McFarlane, S. Lokireddy, S. Bonala, X. Ge, and S. Masuda Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway Diabetologia 54 6 2011 1491 1501
29. C. Zhang, C. McFarlane, S. Lokireddy, S. Masuda, X. Ge, and P.D. Gluckman Inhibition of myostatin protects against diet-induced obesity by enhancing fatty acid oxidation and promoting a brown adipose phenotype in mice Diabetologia 55 1 2012 183 193
30. S. Welle, K. Burgess, and S. Mehta Stimulation of skeletal muscle myofibrillar protein synthesis, p70 S6 kinase phosphorylation, and ribosomal protein S6 phosphorylation by inhibition of myostatin in mature mice Am J Physiol Endocrinol Metab 296 3 2009 E567 E572
31. K. Baar, and K. Esser Phosphorylation of p70(S6k) correlates with increased skeletal muscle mass following resistance exercise Am J Physiol 276 1 Pt 1 1999 C120 C127
32. S. Welle, S. Mehta, and K. Burgess Effect of postdevelopmental myostatin depletion on myofibrillar protein metabolism Am J Physiol Endocrinol Metab 300 6 2011 E993 E1001
33. S.J. Lee Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways PLoS One 2 8 2007 e789
34. M.S. Aoki, A.G. Soares, E.H. Miyabara, I.L. Baptista, and A.S. Moriscot Expression of genes related to myostatin signaling during rat skeletal muscle longitudinal growth Muscle Nerve 40 6 2009 992 999
35. K. Burgess, T. Xu, R. Brown, B. Han, and S. Welle Effect of myostatin depletion on weight gain, hyperglycemia, and hepatic steatosis during five months of high-fat feeding in mice PLoS One 6 2 2011 e17090
36. A.C. McPherron, T. Guo, Q. Wang, and J. Portas Soluble activin receptor type IIB treatment does not cause fat loss in mice with diet-induced obesity Diabetes Obes Metab 14 3 2012 279 282
37. B. Ferrer, B. Navia, M. Giralt, G. Comes, J. Carrasco, and A. Molinero Muscle-specific interleukin-6 deletion influences body weight and body fat in a sex-dependent manner Brain Behav Immun 40 2014 Aug 121 130
38. M. Furukawa, R. Nobusawa, H. Shibata, Y. Eto, and I. Kojima Initiation of insulin secretion in glucose-free medium by activin A Mol Cell Endocrinol 113 1 1995 83 87
39. P. Florio, S. Luisi, P. Marchetti, R. Lupi, L. Cobellis, and C. Falaschi Activin A stimulates insulin secretion in cultured human pancreatic islets J Endocrinol Invest 23 4 2000 231 234
40. L. Bonomi, M. Brown, N. Ungerleider, M. Muse, M.M. Matzuk, and A. Schneyer Activin B regulates islet composition and islet mass but not whole body glucose homeostasis or insulin sensitivity Am J Physiol Endocrinol Metab 303 5 2012 E587 E596
41. D.L. Allen, A.S. Cleary, S.F. Lindsay, A.S. Loh, and J.M. Reed Myostatin expression is increased by food deprivation in a muscle-specific manner and contributes to muscle atrophy during prolonged food deprivation in mice J Appl Physiol 109 3 2010 692 701
42. V.A. Moragianni, K.N. Aronis, J.P. Chamberland, and C.S. Mantzoros Short-term energy deprivation alters activin a and follistatin but not inhibin B levels of lean healthy women in a leptin-independent manner J Clin Endocrinol Metab 96 12 2011 3750 3758
43. M.T. Vamvini, K.N. Aronis, J.P. Chamberland, and C.S. Mantzoros Energy deprivation alters in a leptin- and cortisol-independent manner circulating levels of activin A and follistatin but not myostatin in healthy males J Clin Endocrinol Metab 96 11 2011 3416 3423
44. S. Kersten, J. Seydoux, J.M. Peters, F.J. Gonzalez, B. Desvergne, and W. Wahli Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting J Clin Invest 103 11 1999 1489 1498
45. A. Yndestad, J.W. Haukeland, T.B. Dahl, K. Bjoro, I.P. Gladhaug, and C. Berge A complex role of activin A in non-alcoholic fatty liver disease Am J Gastroenterol 104 9 2009 2196 2205
46. N.A. Ungerleider, L.M. Bonomi, M.L. Brown, and A.L. Schneyer Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice Endocrinology 154 6 2013 2025 2033